Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomas.
Saved in:
| Title: | Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomas. |
|---|---|
| Authors: | Gile JJ; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., McGarrah PW; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Leventakos K; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Sonbol MB; Division of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona, USA., Starr JS; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida, USA., Eiring RA; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Hobday TJ; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Halfdanarson TR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA. |
| Source: | Journal of neuroendocrinology [J Neuroendocrinol] 2023 May; Vol. 35 (5), pp. e13283. Date of Electronic Publication: 2023 May 25. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley & Sons Country of Publication: United States NLM ID: 8913461 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2826 (Electronic) Linking ISSN: 09538194 NLM ISO Abbreviation: J Neuroendocrinol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2826 |
|---|---|
| DOI: | 10.1111/jne.13283 |
